| Literature DB >> 34970259 |
Jing Zhang1,2, Ying Sun3, Jingtong Zheng2.
Abstract
Protozoan parasite infection causes severe diseases in humans and animals, leading to tremendous economic and medical pressure. Natural immunity is the first line of defence against parasitic infection. Currently, the role of natural host immunity in combatting parasitic infection is unclear, so further research on natural host immunity against parasites will provide a theoretical basis for the prevention and treatment of related parasitic diseases. Extracellular traps (ETs) are an important natural mechanism of immunity involving resistance to pathogens. When immune cells such as neutrophils and macrophages are stimulated by external pathogens, they release a fibrous network structure, consisting mainly of DNA and protein, that can capture and kill a variety of extracellular pathogenic microorganisms. In this review, we discuss the relevant recently reported data on ET formation induced by protozoan parasite infection, including the molecular mechanisms involved, and discuss the role of ETs in the occurrence and development of parasitic diseases.Entities:
Keywords: METs; NETs; antimicrobial defense; extracellular traps; protozoan parasites
Mesh:
Year: 2021 PMID: 34970259 PMCID: PMC8712655 DOI: 10.3389/fimmu.2021.770246
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 7.561
Extracellular traps induced by different parasites and the associated signalling pathways.
| Antigen | Cell source | Cell types that produce extracellular traps | Signalling pathway | Reduction in survival rate | Stimulation time | References |
|---|---|---|---|---|---|---|
|
| Mouse | PMNs | ERK1/2 | — | 2 h | ( |
|
| Cattle | PMNs | – | 26% | 2 h | ( |
|
| Human | PMNs | – | — | 1 h | ( |
|
| Mouse and canine | PMNs | – | 14.3-43% | 2 h | ( |
|
| Mouse and rat | Mast cells | Partially PI3K | 13.56% | 18-24 h | ( |
|
| Mouse and rat | Mast cells | – | 9% | 18-24 h | ( |
|
| Mouse | Macrophages | ERK1/2 and p38 MAP | 31.75% | 2.5 h | ( |
|
| Human | Macrophages | P38 and ERK1/2 MAPK | – | 1 h | ( |
|
| Mouse | PMNs | – | 17% | – | ( |
| Hamster | PMNs | – | – | – | ( | |
|
| Mouse | PMNs | – | – | – | ( |
| Human | PMNs | – | – | – | ( | |
|
| Human | PMNs | – | – | 3 h | ( |
|
| Cattle | PMNs | P38 and ERK1/2 MAPK | 34% | 3 h | ( |
|
| Canine | PMNs | ERK 1/2 and p38 MAPK | 47%-52% | – | ( |
| Goat | Monocytes | ERK 1/2 and p38 MAPK | – | – | ( | |
| Goat | PMNs | PI3K pathway | – | – | ( | |
| Cattle | Macrophages | ERK 1/2 and p38 MAPK | – | – | ( | |
| Cattle | PMNs | ERK 1/2 and p38 MAPK | – | – | ( | |
|
| Mouse | PMNs | Raf-MEK-ERK | 25% | 4 h | ( |
| Human | PMNs | Raf-MEK-ERK | – | 6 h | ( | |
| Cat | PMNs | – | 47% | 3 h | ( | |
| Dog | – | – | – | 2 h | ( |